Danhong Injection Combined with Edaravone in Treatment of Acute Cerebral Infarction：An Analysis of 126 Cases

ZHANG Hui; QIU Bo; ZHANG Jing

doi:10.11653/syfj2013180315

您当前的位置：

首页 >

文章列表页 >

Danhong Injection Combined with Edaravone in Treatment of Acute Cerebral Infarction：An Analysis of 126 Cases

更新时间：2024-01-04

- Danhong Injection Combined with Edaravone in Treatment of Acute Cerebral Infarction：An Analysis of 126 Cases
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 19, Issue 18, Pages: 315-317(2013)
- 作者机构：
- 作者简介：
- 基金信息：
- DOI：10.11653/syfj2013180315
  CLC：
- Published：2013
- 稿件说明：
移动端阅览
ZHANG Hui, QIU Bo, ZHANG Jing. Danhong Injection Combined with Edaravone in Treatment of Acute Cerebral Infarction：An Analysis of 126 Cases[J]. Chinese journal of experimental traditional medical formulae, 2013, 19(18): 315-317.
DOI：

ZHANG Hui, QIU Bo, ZHANG Jing. Danhong Injection Combined with Edaravone in Treatment of Acute Cerebral Infarction：An Analysis of 126 Cases[J]. Chinese journal of experimental traditional medical formulae, 2013, 19(18): 315-317. DOI： 10.11653/syfj2013180315.

摘要

目的: 探讨临床上丹红注射液联合依达拉奉治疗急性脑梗死的有效性与安全性。方法: 随机将126例急性脑梗死患者分为对照组和实验组各63例

两组均使用每日1次吸氧、抗凝、保护脑细胞等一般康复措施作为基础治疗

此外对照组给予依达拉奉静脉滴注

实验组给予依达拉奉和丹红注射液联合静脉滴注

10 d为1个疗程。3个疗程后对比两组治疗前后神经功能损害程度和日常生活能力改善情况。结果: 实验组比对照组的神经功能缺损程度NIHSS评分明显降低

而日常生活能力ADL评分明显提高

且均具有统计学显著性 (P<0.05)。总体有效率上

实验组92.06%明显优于对照组的69.84%。结论: 丹红注射液联合依达拉奉治疗急性脑梗死疗效确切

比使用依达拉奉单药治疗效果更好

并且安全性好

值得在临床上进行推广。

Abstract

Objective: To investigate the clinical application value of Danhong injection combined with edaravone in treatment of acute cerebral infarction. Method: One hundred and twenty-six cases patients with acute cerebral infarction were selected

63 of them in control group and experimental group each. Both group received general rehabilitation measures such as daily oxygen uptake

anticoagulation treatment

brain cells protection. Additionally

control group got edaravone intravenously only and experimental group received Danhong injection combined with edaravone. 10 days was taken as a course. After three courses

degree of neurological impairment and improvement of daily living activities was evaluated and compared with before. Result: The NIHSS score of neurological deficit was significant lower in the experimental group than the control group

and the activities of daily living(ADL) score of daily living ability was significant higher in the experimental group than the control group. Both the difference were statistically significant. Overall efficiency of the experimental group was 91.67%

significantly better than the control group's 70.21%. Conclusion: It is a safe and effective method to use Danhong injection combined with edaravone in treatment of acute cerebral infarction. The combination therapy is better than edaravone monotherapy and it's worthy of promotion in clinical practice.

关键词

Keywords

references

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Edaravone Combined with Danhong Injection in Treating Acute Cerebral Infarction

Influence of Edaravone on Intracranial Artery Hemodynamics in Advanced Age Patients with Acute Cerebral Infarction

Clinical Effect of Shuxuening Combined with Edaravone for Acute Cerebral Infarction

Efficacy-driving Mechanism of Danhong Injection for Stable Angina Pectoris Based on Composition-activity Relationship of Target Modules

Related Author

TIAN Zi-you

CHEN Sai-zhen

XU Li-jun

LIN Li-fen

Zhang Bin

LIN Ren-biao

ZHANG Wei

PAN Yun-zhi

Related Institution

Forth Department of Neurology,Third Affiliated Hospital of Qiqihar MedicalCollege

Institute of Basic Theory for Chinese Medicine，China Academy of Chinese Medical Sciences

Institute of Basic Research in Clinical Medicine，China Academy of Chinese Medical Sciences

Institute of Chinese Materia Medica， China Academy of Chinese Medical Sciences， State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs， Institute of Chinese Materia Medica， China Academy of Chinese Medical Sciences

The Affiliated Hospital of Nanjing University of Chinese Medicine/ Jiangsu Province Hospital of Chinese Medicine

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰